State of Alaska Department of Revenue’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-80,212
Closed -$355K 1588
2024
Q4
$355K Sell
80,212
-5
-0% -$20 ﹤0.01% 1488
2024
Q3
$330K Sell
80,217
-1,911
-2% -$10.3K ﹤0.01% 1526
2024
Q2
$535K Sell
82,128
-1,570
-2% -$11.1K 0.01% 1343
2024
Q1
$729K Sell
83,698
-827
-1% -$10K 0.01% 1205
2023
Q4
$966K Sell
84,525
-963
-1% -$9.53K 0.01% 1023
2023
Q3
$823K Sell
85,488
-3,438
-4% -$33.7K 0.01% 1062
2023
Q2
$946K Sell
88,926
-2,461
-3% -$26.4K 0.01% 1012
2023
Q1
$961K Sell
91,387
-1,541
-2% -$17.3K 0.01% 1003
2022
Q4
$1.15M Buy
92,928
+633
+0.7% +$7.18K 0.01% 880
2022
Q3
$956K Sell
92,295
-24,085
-21% -$273K 0.01% 939
2022
Q2
$1.34M Buy
+116,380
New +$1.37M 0.02% 802

Other funds holding IRWD

State of Alaska Department of Revenue's IRWD Position: Q1 2025 in Review

State of Alaska Department of Revenue sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 80,212 shares — an estimated $355K sold.

State of Alaska Department of Revenue first reported a position in IRWD in Q2 2022 and held it in 11 quarters. The position peaked at $1.34M in Q2 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • State of Alaska Department of Revenue reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 80,212 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $355K.
  • State of Alaska Department of Revenue first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • State of Alaska Department of Revenue's Ironwood Pharmaceuticals position peaked at $1.34M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2025, filed 21 Apr 2025.